development history
2011年
shanghai dishuo becken biotechnology co., ltd. was founded to locate allogeneic bone product development and transplantation immune technology development.
2012年
the company establishes a research and development laboratory at no. 35 guilin road, xuhui district, shanghai (china red cross foreign aid material supply station).
the company moved to no. 1010 wangqiao road, pudong new area, shanghai, to establish a research and development laboratory and prepare to build a gmp plant for allogeneic bone and in vitro diagnostic reagent.
the company signed a joint technology development agreement with xijing hospital orthopaedic specialized hospital of fourth military medical university (all military orthopaedic research institute) to jointly develop a series of allogeneic skeleton products. 报错
2013年
the company's first invention patent "hla gene specific pcr amplification primers and hla typing methods and kits" was authorized.
the company has completed angel round financing and obtained financing support from qingyuan capital.
two wholly-owned subsidiaries, shanghai dishuo becken biotechnology co., ltd. and shanghai dishuo becken biomaterials co., ltd., were established to develop and produce in vitro diagnostic reagents and allogenic tissue materials respectively.
the signing of the patent transfer agreement between the company and southern medical university on a new type of allograft and its preparation method is an important measure for the company to ensure the leading products and services and the competitiveness of the enterprise.
2014年
for the first time, the company won the bid and became one of the service laboratories of data typing and testing in the chinese bone marrow bank.
2015年
the company's headquarters is located in shanghai international medical park, becoming one of the first batches of enterprises in the fourth phase of the international medical park. a round of financing was completed in the same period, and tianfeng capital financing support was obtained.
the company's first third-party medical laboratory, shanghai dishuo becken medical laboratory, was approved to be established. the company held the first pujiang forum on transplantation immunity, which opened the company's comprehensive academic promotion path and academic brand strategy in the field of transplantation immunity.
the company, together with shanghai institute of hematology and jean dausset laboratory of france, has established the china-france hla technology research center to promote the establishment of china's hla technology platform.
2016年
in october 2016, shanghai dishuo becken medical laboratory obtained the certificate of technical examination and acceptance of clinical gene amplification laboratory.
2017年
in february 2017, many benchmark organ transplantation hospitals in the united nations established a multi-center for clinical research on biomarkers of acute rejection after organ transplantation.
in november 2017, shanghai dishuo becken medical laboratory co., ltd. was certified as a high-tech enterprise.
in november 2017, shenzhen dishuo becken medical laboratory was licensed by medical institutions.
2018年
in january 2018, shanghai dishuo becken medical laboratory co., ltd. was certified as a "specialized and new" sme in shanghai.
in november 2018, the company's academician expert workstation passed the annual acceptance review and acceptance, supported by supporting funds of zhangjiang management committee.
in december 2018, shanghai dishuo becken medical laboratory co., ltd. was certified by pudong new area enterprise r&d institution.
2019年
in may 2019, two medical laboratories in shanghai and shenzhen passed the first external quality assessment in 2019 by the national health care commission's inspection center with full marks.
shenzhen headquarters
address: building a17, life science industrial park, kwai chung street, dapeng new district, shenzhenshanghai headquarters
address: building 21, phase 4, shanghai international medical parkscan on us
©九游会j9官方登录入口 copyright shenzhen tissue bank precision medicine co., ltd. 九游会j9官方登录入口 copyright